Osaic Holdings’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3K | Buy |
+3,705
| New | +$11.3K | ﹤0.01% | 5703 |
|
|
2025
Q1 | – | Sell |
-4,018
| Closed | -$12.2K | – | 7593 |
|
|
2024
Q4 | $12.2K | Sell |
4,018
-37
| -0.9% | -$112 | ﹤0.01% | 5605 |
|
|
2024
Q3 | $21K | Buy |
4,055
+641
| +19% | +$3.33K | ﹤0.01% | 5316 |
|
|
2024
Q2 | $8.77K | Buy |
3,414
+679
| +25% | +$1.75K | ﹤0.01% | 5780 |
|
|
2024
Q1 | $13.5K | Sell |
2,735
-908
| -25% | -$4.47K | ﹤0.01% | 5528 |
|
|
2023
Q4 | $32.1K | Sell |
3,643
-890
| -20% | -$7.84K | ﹤0.01% | 5183 |
|
|
2023
Q3 | $52K | Buy |
4,533
+402
| +10% | +$4.61K | ﹤0.01% | 4972 |
|
|
2023
Q2 | $105K | Buy |
4,131
+433
| +12% | +$11K | ﹤0.01% | 4401 |
|
|
2023
Q1 | $119K | Buy |
3,698
+98
| +3% | +$3.16K | ﹤0.01% | 4298 |
|
|
2022
Q4 | $65.7K | Buy |
3,600
+276
| +8% | +$5.04K | ﹤0.01% | 4734 |
|
|
2022
Q3 | $90K | Buy |
3,324
+486
| +17% | +$13.2K | ﹤0.01% | 4465 |
|
|
2022
Q2 | $39K | Hold |
2,838
| – | – | ﹤0.01% | 5138 |
|
|
2022
Q1 | $56K | Buy |
2,838
+1,071
| +61% | +$21.1K | ﹤0.01% | 5010 |
|
|
2021
Q4 | $29K | Sell |
1,767
-415
| -19% | -$6.81K | ﹤0.01% | 5516 |
|
|
2021
Q3 | $60K | Sell |
2,182
-34
| -2% | -$935 | ﹤0.01% | 4964 |
|
|
2021
Q2 | $65K | Buy |
2,216
+241
| +12% | +$7.07K | ﹤0.01% | 4836 |
|
|
2021
Q1 | $55K | Sell |
1,975
-82
| -4% | -$2.28K | ﹤0.01% | 4813 |
|
|
2020
Q4 | $58K | Sell |
2,057
-305
| -13% | -$8.6K | ﹤0.01% | 4446 |
|
|
2020
Q3 | $59K | Buy |
2,362
+747
| +46% | +$18.7K | ﹤0.01% | 4181 |
|
|
2020
Q2 | $39K | Sell |
1,615
-804
| -33% | -$19.4K | ﹤0.01% | 4358 |
|
|
2020
Q1 | $37K | Buy |
+2,419
| New | +$37K | ﹤0.01% | 4200 |
|